Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct;8(5):768-777.
doi: 10.1002/jcsm.12209. Epub 2017 Jul 15.

Circulating Activin A predicts survival in cancer patients

Audrey Loumaye  1   2 , Marie de Barsy  2 , Maxime Nachit  1 , Pascale Lause  1 , Aline van Maanen  3 , Pierre Trefois  4 , Damien Gruson  1   5 , Jean-Paul Thissen  1   2
Affiliations

Circulating Activin A predicts survival in cancer patients

Audrey Loumaye et al. J Cachexia Sarcopenia Muscle. 2017 Oct.

Abstract

Background: Several experimental evidences pinpoint the possible role of Activin A (ActA) as a driver of cancer cachexia. Supporting this hypothesis, we showed recently that human cancer cachexia is associated with high ActA levels. Moreover, ActA levels were correlated with body weight loss and skeletal muscle density, two prognostic factors in cancer patients. Our goal was therefore to investigate the value of ActA to predict survival in cancer patients.

Methods: Patients with colorectal or lung cancer were prospectively enrolled at the time of diagnosis or relapse between January 2012 and March 2014. At baseline, patients had clinical, nutritional, and functional assessment. Body composition and skeletal muscle density were measured by CT scan, and plasma ActA concentrations were determined. Overall survival (OS) was analysed since inclusion to 24 months later.

Results: Survival data were available for 149 patients out of 152. Patients with high ActA (≥408 pg/mL) had lower OS than those with low levels, regardless the type of cancer (OS in colorectal cancer, 50% vs. 79%, P < 0.05; and in lung cancer, 27% vs. 67%, P = 0.001). The multivariable analysis confirmed the prognostic value of ActA independently of tumour stage or inflammatory markers, particularly in lung cancer. Low muscularity was also an independent prognostic factor.

Conclusions: Our study demonstrates that high ActA level is an independent prognosis factor of survival in cancer patients. More than a basic marker of the severity of the neoplastic disease or of the inflammatory process, ActA seems to influence survival by contributing to the development of cachexia and loss of skeletal muscle mass.

Keywords: Activin A; Biomarker; Cachexia; Colorectal cancer; Lung cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan–Meier survival curves according to muscularity (above) and skeletal muscle density (SMD) (below) for total population (n = 138), colorectal cancer (n = 87), and lung cancer (n = 51).
Figure 2
Figure 2
Kaplan–Meier survival curves according to plasma Activin A levels [quartiles and cut‐off statistically determinated (408 pg/mL)] for total population (n = 152), colorectal cancer (n = 94), and lung cancer (n = 58).
Figure 3
Figure 3
Kaplan–Meyer progression‐free survival curves according to plasma Activin A levels in first diagnosis colorectal cancer (n = 73).
Figure 4
Figure 4
Kaplan–Meyer survival curves according to plasma Activin A levels in stages III and IV lung cancer (n = 33).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Fearon KC, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 2012;16:153–166. - PubMed
    1. Aubrey J, Esfandiari N, Baracos VE, Buteau FA, Frenette J, Putman CT, et al. Measurement of skeletal muscle radiation attenuation and basis of its biological variation. Acta Physiol (Oxf) 2014;210:489–497. - PMC - PubMed
    1. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population‐based study. Lancet Oncol 2008;9:629–635. - PubMed
    1. Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013;31:1539–1547. - PubMed
    1. Kazemi‐Bajestani SM, Mazurak VC, Baracos V. Computed tomography‐defined muscle and fat wasting are associated with cancer clinical outcomes. Semin Cell Dev Biol 2016;54:2–10. - PubMed

MeSH terms